OTC Markets EXMKT - Delayed Quote USD
Antibe Therapeutics Inc. (ATBPF)
0.2156
-0.0004
(-0.19%)
As of April 16 at 4:00:00 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Curtis (Scott Wilson) Senior Officer of Issuer | Acquisition or disposition in the public market | Mar 7, 2024 | 115,000 |
| Legault (Daniel Marcel) Director of Issuer | Acquisition or disposition in the public market | Mar 7, 2024 | 1,003,296 |
Related Tickers
MMIRF MedMira Inc.
0.0207
0.00%
MSCL.TO Satellos Bioscience Inc.
0.6600
+1.54%
MIR.V MedMira Inc.
0.0850
0.00%
MDNAF Medicenna Therapeutics Corp.
0.7454
+5.87%
TVGN Tevogen Bio Holdings Inc.
1.0850
+4.33%
CANF Can-Fite BioPharma Ltd.
1.1150
+1.36%
CNTB Connect Biopharma Holdings Limited
0.8125
+2.85%
CRDF Cardiff Oncology, Inc.
2.6750
+7.43%
TNYA Tenaya Therapeutics, Inc.
0.4203
-6.57%
PCVX Vaxcyte, Inc.
33.03
+13.88%